Project Grant R01CA309495
- Federal Grant Award Summary Rutgers The State University of New Jersey, Robert Wood Johnson School of Nursing received a $861,930 Project Grant from the National Cancer Institute (NCI) under the Cancer Detection and Diagnosis Research Program (CFDA 93.394), awarded August 7, 2025, with a completion date of July 31, 2028. The award funds development and testing of a dyadic digital skin cancer prevention intervention targeting adolescents and their parents. The intervention leverages smartphone...
- Federal Grant Award Summary Tufts University School of Medicine received a $883,825.75 Project Grant award from the National Cancer Institute under the Cancer Cause and Prevention Research program (CFDA 93.393) on May 15, 2025. This research initiative leverages existing leukocyte deoxyribonucleic acid (DNA) methylation data to identify biological pathways linking obesity to 13 distinct cancer types. The project utilizes data from the Atherosclerosis Risk in Communities Study (ARIC) to...
- Federal Grant Award Summary The National Cancer Institute (NCI) awarded University of Miami a $2.75 million Project Grant on September 12, 2025, under the Cancer Cause and Prevention Research program (CFDA 93.393) to conduct a four-year randomized controlled trial examining the effects of remotely-delivered cognitive behavioral stress management (R-CBSM) on cancer-accelerated aging in older breast cancer survivors. The study will enroll 192 distressed, post-menopausal breast cancer survivors...
- Federal Grant Award Summary The National Cancer Institute (CFDA 93.393 – Cancer Cause and Prevention Research) awarded the University of Virginia a $3.36 million Project Grant on September 24, 2025, to evaluate the efficacy and optimal sequencing of two evidence-based digital interventions designed to address co-occurring insomnia and depression in breast cancer survivors. The research will utilize SHUTi (an automated cognitive-behavioral therapy application for insomnia) and IntelliCare (a...
- Federal Grant Award Summary The National Cancer Institute awarded a $164,484 Project Grant to The University of Kentucky Research Foundation on August 11, 2025, under the Cancer Cause and Prevention Research program (CFDA 93.393). This award supports a research initiative focused on developing and evaluating health communications targeting adults who smoke nondaily (ASN)—a population representing approximately one-third of current adult cigarette smokers in the United States yet demonstrating...
- Federal Grant Award Summary The University of Iowa received a $155,500 Project Grant from the National Cancer Institute under the Cancer Cause and Prevention Research program (CFDA 93.393), awarded July 18, 2025, with a completion date of June 30, 2027. The grant supports research establishing an in vivo Sleeping Beauty (SB) transposon mutagenesis screen in a nevi-prone zebrafish model to identify and characterize novel genetic drivers of melanomagenesis. The research addresses a critical...
- Federal Grant Award Summary The University of Texas Health Science Center at Houston received a $401,115 Project Grant award from the National Cancer Institute under the Cancer Cause and Prevention Research program (CFDA 93.393), effective May 1, 2026 through April 30, 2028. This research initiative will identify the mechanisms of action underlying Expert Recommendations for Implementing Change (ERIC) implementation strategies used in cancer prevention and control. The project employs an...
- Federal Grant Award Summary New York University received a $442,750 Project Grant from the National Cancer Institute (National Institutes of Health) under the Cancer Cause and Prevention Research program (CFDA 93.393), awarded on September 23, 2025, with completion targeted for August 31, 2027. This research project delivers a systematic, theory-based analysis of cervical cancer control policy implementation in African low- and middle-income countries through three primary research activities:...
- Federal Grant Award Summary The National Cancer Institute (NCI) awarded The Institute For Cancer Research a Project Grant of $766,439 under the Cancer Cause and Prevention Research program (CFDA 93.393) for the period April 1, 2026 through March 31, 2031. This research project focuses on intratumor heterogeneity as a correlate of clinical outcomes in bladder cancer patients pursuing cystectomy avoidance strategies. The primary deliverables include: (1) scientific investigation into the genetic...
- Federal Grant Award Summary The University of Pennsylvania received a $441,578 Project Grant from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393), effective May 1, 2025, through April 30, 2030. This research initiative investigates the role of immunosuppression and environmental exposures on keratinocyte carcinoma (KC) risk in solid organ transplant recipients. The project addresses a critical knowledge gap by developing evidence-based...
The National Cancer Institute (NCI), under the Cancer Cause and Prevention Research program (CFDA 93.393), awarded the University of Connecticut a $444,991 Project Grant effective May 1, 2026 through April 30, 2030 to conduct a randomized controlled trial of a dissonance-based sun safety intervention targeting young adult tanners. The research will develop and evaluate a scalable intervention leveraging cognitive dissonance theory—an approach successfully implemented in eating disorder prevention across 125 countries and 3.5 million participants—adapted specifically for melanoma prevention. The intervention incentivizes young adult tanners to create anti-tanning social media messaging and recruit peers to engage with these messages, addressing the critical public health concern that three-quarters of melanomas in individuals aged 20–39 are attributable to tanning behavior and that most young adults tan due to internalized beliefs that tanned skin improves physical appearance. The study builds upon preliminary feasibility findings demonstrating high participation rates and will generate evidence on the effectiveness, scalability, and implementation potential of dissonance-based interventions for skin cancer prevention in this high-risk population. Deliverables will include trial results, implementation data, and potentially a validated intervention model that can be disseminated across academic and community settings to reduce preventable melanoma incidence among young adults.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $445.0k | 3/30/26 |